Role of spleen tyrosine kinase in liver diseases

doi:10.3748/wjg.v26.i10.1005

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12180)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

655

WORD

232

HTML

6709

Figures (1-4)

755

Tables (1-2)

333

Sum=8684

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

595

Download

825

Sum=1420

Publishing Process of This Article

Item

Count

Browse

890

Download

1186

Sum=2076

Mar 14, 2020 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Mar 14, 2020; 26(10): 1005-1019
Published online Mar 14, 2020. doi: 10.3748/wjg.v26.i10.1005

Full Size Figure Download Figure

Figure 4 Molecular structure of several spleen tyrosine kinase inhibitors. R406, GS-9973, PRT062070, and Piceatannol have been studied in liver diseases, while R788 and TAK-659 are being investigated in other diseases.

Citation: Kurniawan DW, Storm G, Prakash J, Bansal R. Role of spleen tyrosine kinase in liver diseases. World J Gastroenterol 2020; 26(10): 1005-1019
URL: https://www.wjgnet.com/1007-9327/full/v26/i10/1005.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i10.1005